Avantor Zukünftiges Wachstum

Future Kriterienprüfungen 3/6

Avantor wird ein jährliches Gewinn- und Umsatzwachstum von 25.1% bzw. 4.4% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 29.5% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 13.9% betragen.

Wichtige Informationen

25.0%

Wachstumsrate der Gewinne

29.8%

EPS-Wachstumsrate

Life Sciences Gewinnwachstum	18.1%
Wachstumsrate der Einnahmen	4.4%
Zukünftige Eigenkapitalrendite	12.9%
Analystenabdeckung	Good
Zuletzt aktualisiert	25 Sep 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

Why We're Not Concerned About Avantor, Inc.'s (NYSE:AVTR) Share Price

Sep 02

Avantor, Inc. (NYSE:AVTR) Shares Could Be 35% Below Their Intrinsic Value Estimate

Aug 15

Avantor: Contracting Growth And Returns On Equity At 37x Earnings - Enemies To The Value Investor

Dec 01

These 4 Measures Indicate That Avantor (NYSE:AVTR) Is Using Debt Extensively

Oct 24

Is Now An Opportune Moment To Examine Avantor, Inc. (NYSE:AVTR)?

Oct 03

Is There An Opportunity With Avantor, Inc.'s (NYSE:AVTR) 32% Undervaluation?

Sep 10

Avantor: Customers Destocking, Order Volumes Down, Challenges To Rating (Rating Downgrade)

Sep 08

Avantor (NYSE:AVTR) Has A Pretty Healthy Balance Sheet

Jul 10

Avantor: Promising Long-Term Buy With Potential For Opportunistic Entry

Jun 28

At US$19.71, Is Avantor, Inc. (NYSE:AVTR) Worth Looking At Closely?

Jun 22

A Look At The Fair Value Of Avantor, Inc. (NYSE:AVTR)

Jun 04

Do Avantor's (NYSE:AVTR) Earnings Warrant Your Attention?

Apr 17

Is Avantor (NYSE:AVTR) A Risky Investment?

Apr 04

Why Avantor, Inc. (NYSE:AVTR) Could Be Worth Watching

Mar 22

Avantor Non-GAAP EPS of $0.32 beats by $0.02, revenue of $1.8B beats by $10M

Feb 03

Does This Valuation Of Avantor, Inc. (NYSE:AVTR) Imply Investors Are Overpaying?

Feb 02

Avantor: Re-Rating To Buy, Paying Fair Price At 17x Forward P/E (Rating Upgrade)

Jan 28

With EPS Growth And More, Avantor (NYSE:AVTR) Makes An Interesting Case

Jan 09

Here's Why Avantor (NYSE:AVTR) Can Manage Its Debt Responsibly

Dec 27

Is It Time To Consider Buying Avantor, Inc. (NYSE:AVTR)?

Dec 14

Avantor: Reduce To Hold, Awaiting Convergence Of Price, Fundamentals

Nov 10

Avantor Non-GAAP EPS of $0.34 beats by $0.01, revenue of $1.86B beats by $10M

Oct 28

Estimating The Intrinsic Value Of Avantor, Inc. (NYSE:AVTR)

Oct 27

Avantor raised to Buy at Citi on valuation disconnect

Oct 05

Do Avantor's (NYSE:AVTR) Earnings Warrant Your Attention?

Oct 03

We Think Avantor (NYSE:AVTR) Can Stay On Top Of Its Debt

Sep 21

Is Avantor, Inc. (NYSE:AVTR) Potentially Undervalued?

Sep 09

Avantor Non-GAAP EPS of $0.37 misses by $0.01, revenue of $1.91B misses by $70M

Jul 28

Estimating The Intrinsic Value Of Avantor, Inc. (NYSE:AVTR)

Jul 18

Avantor, Inc.'s (NYSE:AVTR) P/E Is On The Mark

Jul 05

Here's Why Avantor (NYSE:AVTR) Can Manage Its Debt Responsibly

Jun 20

Avantor: Narrowing The Relative Valuation Gap

May 20

I Ran A Stock Scan For Earnings Growth And Avantor (NYSE:AVTR) Passed With Ease

May 15

Gewinn- und Umsatzwachstumsprognosen

NYSE:AVTR - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (USD Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
12/31/2026	7,641	710	889	1,060	15
12/31/2025	7,254	616	851	1,010	20
12/31/2024	6,915	407	615	780	21
6/30/2024	6,826	360	736	905	N/A
3/31/2024	6,867	260	639	792	N/A
12/31/2023	6,967	321	724	870	N/A
9/30/2023	7,039	364	695	824	N/A
6/30/2023	7,176	423	721	852	N/A
3/31/2023	7,342	610	774	911	N/A
12/31/2022	7,512	662	710	844	N/A
9/30/2022	7,625	598	799	939	N/A
6/30/2022	7,603	572	809	943	N/A
3/31/2022	7,551	534	858	979	N/A
12/31/2021	7,386	508	843	954	N/A
9/30/2021	7,269	466	867	959	N/A
6/30/2021	7,040	267	904	978	N/A
3/31/2021	6,660	169	740	804	N/A
12/31/2020	6,394	52	868	930	N/A
9/30/2020	6,127	71	657	711	N/A
6/30/2020	6,026	135	576	627	N/A
3/31/2020	6,079	-226	480	532	N/A
12/31/2019	6,040	-335	302	354	N/A
9/30/2019	5,990	-514	292	337	N/A
6/30/2019	5,981	-554	206	247	N/A
3/31/2019	5,926	-330	192	229	N/A
12/31/2018	5,864	-356	163	201	N/A
9/30/2018	5,120	-639	-58	-16	N/A
12/31/2017	1,247	-415	N/A	-167	N/A
12/31/2016	691	-42	N/A	73	N/A
12/31/2015	637	22	N/A	125	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: AVTRDas prognostizierte Gewinnwachstum (25.1% pro Jahr) liegt über der Sparquote (2.5%).

Ertrag vs. Markt: AVTRDie Erträge des Unternehmens (25.1% pro Jahr) werden voraussichtlich schneller wachsen als der Markt US (15.1% pro Jahr).

Hohe Wachstumserträge: AVTREs wird erwartet, dass die Erträge des Unternehmens in den nächsten 3 Jahren erheblich steigen werden.

Einnahmen vs. Markt: AVTRDie Einnahmen des Unternehmens (4.4% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (8.8% pro Jahr).

Hohe Wachstumseinnahmen: AVTRDie Einnahmen des Unternehmens (4.4% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: AVTRDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (13.9%).

Avantor Zukünftiges Wachstum

Future Kriterienprüfungen 3/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Price target increased by 7.7% to US$27.21

Avantor, Inc. Provides Earnings Guidance for the First Quarter for the First Quarter and Full Year 2024

Consensus EPS estimates fall by 40%

Consensus EPS estimates fall by 10%

Price target decreased by 7.8% to US$25.71

Price target decreased to US$29.25

Recent updates

Avantor, Inc. to Report Q3, 2024 Results on Oct 25, 2024

Why We're Not Concerned About Avantor, Inc.'s (NYSE:AVTR) Share Price

Avantor, Inc. (NYSE:AVTR) Shares Could Be 35% Below Their Intrinsic Value Estimate

Avantor: Yet To Evidence Economic Value For Valuation Repricing, Reiterate Hold

Second quarter 2024 earnings: EPS misses analyst expectations

Investor sentiment improves as stock rises 23%

At US$20.82, Is Avantor, Inc. (NYSE:AVTR) Worth Looking At Closely?

Avantor, Inc. Announces New J. T. Baker Cell Lysis Solution and J. T. Baker Endonuclease

Avantor, Inc. to Report Q2, 2024 Results on Jul 26, 2024

Avantor, Inc Announces Executive Changes

We Think Avantor (NYSE:AVTR) Is Taking Some Risk With Its Debt

First quarter 2024 earnings: EPS misses analyst expectations

Are Investors Undervaluing Avantor, Inc. (NYSE:AVTR) By 32%?

Avantor, Inc.'s (NYSE:AVTR) Popularity With Investors Is Clear

Avantor, Inc. to Report Q1, 2024 Results on Apr 26, 2024

Avantor, Inc., Annual General Meeting, May 09, 2024

Executive VP of Biopharma Production notifies of intention to sell stock

We Think You Can Look Beyond Avantor's (NYSE:AVTR) Lackluster Earnings

Full year 2023 earnings: EPS misses analyst expectations

Price target increased by 7.7% to US$27.21

Avantor, Inc. Provides Earnings Guidance for the First Quarter for the First Quarter and Full Year 2024

Is Avantor (NYSE:AVTR) A Risky Investment?

Avantor, Inc. to Report Q4, 2023 Results on Feb 14, 2024

Should You Think About Buying Avantor, Inc. (NYSE:AVTR) Now?

Now 20% undervalued

Getting In Cheap On Avantor, Inc. (NYSE:AVTR) Might Be Difficult

Are Investors Undervaluing Avantor, Inc. (NYSE:AVTR) By 23%?

Avantor, Inc. Announces Executive Changes

Avantor: Contracting Growth And Returns On Equity At 37x Earnings - Enemies To The Value Investor

Third quarter 2023 earnings: EPS misses analyst expectations

New minor risk - Profit margin trend

These 4 Measures Indicate That Avantor (NYSE:AVTR) Is Using Debt Extensively

Is Now An Opportune Moment To Examine Avantor, Inc. (NYSE:AVTR)?

High number of new directors

Avantor, Inc. to Report Q3, 2023 Results on Oct 27, 2023

Avantor, Inc. Announces Executive Changes

Avantor, Inc. Announces New Scientific Advisory Board

Is There An Opportunity With Avantor, Inc.'s (NYSE:AVTR) 32% Undervaluation?

Avantor: Customers Destocking, Order Volumes Down, Challenges To Rating (Rating Downgrade)

Consensus EPS estimates fall by 40%

New minor risk - Earnings quality

Now 25% undervalued

Avantor, Inc. Announces Chief Financial Officer Changes

Avantor (NYSE:AVTR) Has A Pretty Healthy Balance Sheet

Avantor, Inc. to Report Q2, 2023 Results on Jul 28, 2023

Avantor: Promising Long-Term Buy With Potential For Opportunistic Entry

At US$19.71, Is Avantor, Inc. (NYSE:AVTR) Worth Looking At Closely?

A Look At The Fair Value Of Avantor, Inc. (NYSE:AVTR)

Thomas A. Szlosek to Leave as Executive Vice President of Avantor, Inc., Effective on August 2, 2023

Consensus EPS estimates fall by 10%

Price target decreased by 7.8% to US$25.71

First quarter 2023 earnings: EPS misses analyst expectations

Do Avantor's (NYSE:AVTR) Earnings Warrant Your Attention?

Is Avantor (NYSE:AVTR) A Risky Investment?

Why Avantor, Inc. (NYSE:AVTR) Could Be Worth Watching

Investor sentiment deteriorates as stock falls 15%

Full year 2022 earnings: Revenues and EPS in line with analyst expectations

Avantor Non-GAAP EPS of $0.32 beats by $0.02, revenue of $1.8B beats by $10M

Does This Valuation Of Avantor, Inc. (NYSE:AVTR) Imply Investors Are Overpaying?

Avantor: Re-Rating To Buy, Paying Fair Price At 17x Forward P/E (Rating Upgrade)

With EPS Growth And More, Avantor (NYSE:AVTR) Makes An Interesting Case

Avantor, Inc. to Report Q4, 2022 Results on Feb 03, 2023

Here's Why Avantor (NYSE:AVTR) Can Manage Its Debt Responsibly

Is It Time To Consider Buying Avantor, Inc. (NYSE:AVTR)?

President recently bought US$314k worth of stock

Avantor, Inc. Announces Retirement of Matt Holt from the Board of Directors

High number of new directors

Avantor: Reduce To Hold, Awaiting Convergence Of Price, Fundamentals

Price target decreased to US$29.25